Latest Strategic Partnerships News

Microba Life Sciences reports robust growth in microbiome diagnostic testing across Australia and the UK, while advancing US market entry plans and transitioning its Therapeutics business to a partnering model.

Xanadu Mines has transitioned operatorship of its flagship Kharmagtai project to Zijin Mining, delivered key feasibility milestones, and is now exploring strategic funding and corporate options amid a solid cash position.

INOVIQ Limited reports significant progress in its exosome-based cancer diagnostics and therapeutics, including expanded customer adoption, advanced AI screening tests, and strategic partnerships with leading research centres.

Charger Metals NL reported strong progress in its lithium and gold exploration during the March 2025 quarter, supported by Rio Tinto’s $1.1 million funding at Lake Johnston and the full acquisition of the Bynoe Lithium Project. High-grade lithium intersections and promising gold targets underpin its growth strategy.

Wide Open Agriculture has inked an exclusive 18-month distribution agreement with Univar Solutions China to market its lupin protein products, marking a strategic push into the lucrative Chinese plant-based protein sector.

European Lithium Limited reports a maiden 45 million tonne rare earth resource at its Greenland Tanbreez Project, alongside a $24.5 million capital raise by its majority-owned Critical Metals Corp, underpinning its global lithium and rare earth ambitions.

Cobre Limited has inked a US$25 million earn-in agreement with BHP for its Kitlanya copper projects in Botswana, while delivering promising assay results at Ngami and advancing its high purity quartz project in Australia.

Kalamazoo Resources has secured $800,000 through a share placement to fund critical due diligence at its Ashburton Gold Project and advance exploration across multiple Victorian and Western Australian sites.

Galan Lithium has locked in a binding funding and offtake agreement with Authium Limited for its Hombre Muerto West project, significantly reducing capital and operating costs. The company raised approximately A$13 million via placement and plans further shareholder funding, aiming for lithium chloride production in H1 2026.

Noxopharm Limited has successfully cleared key preclinical hurdles for its SOF-SKN™ lupus drug and expanded its Sofra™ platform collaborations, supported by fresh funding to propel upcoming clinical trials.

Future Metals NL has confirmed significant copper-nickel-PGM mineralisation at its Eileen Bore Prospect, unveiling a newly defined 4.5km intrusion. The company also secured A$4.2 million through a placement and planned rights issue to advance development and explore strategic processing partnerships.

Novatti Group Limited has achieved a key turnaround milestone by reporting positive cash EBITDA of $100k in Q3 FY25, alongside record quarterly revenue of $13.4 million and improved margins in its core Payments AU/NZ business.